S Flohé1, S B Flohé, F U Schade, C Waydhas. 1. Department of Trauma Surgery, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany. sascha.flohe@uni-duisburg-essen.de
Abstract
BACKGROUND: [corrected] Severe injury leads to a severe deterioration of the patients' immune response. The changes of the immune response after severe injury include a broad range of immune functions and may result in a status of immunosuppression, which could favor infectious complications. Therefore, immunostimulating therapies have been introduced in the therapy for severely injured patients in clinical and experimental settings. OBJECTIVES: The article summarizes actual immunomodulating approaches in the treatment of trauma patients and therapeutic strategies avoiding additional immune deteriorations. RESULTS: Examples for an immunostimulating approach in trauma patients are interferon gamma and the granulocyte macrophage-colony-stimulating factor (GM-CSF), which are summarized in this review in detail. However, the effect of such an interference in the patients' immune response with all its different cellular targets is not yet clearly understood, and most studies focus on the reaction of circulating monocytes. In addition, further immunomodulating strategies, including nutritional support, are addressed. However, clinically established therapeutic immunomodulating strategies in trauma care so far do not exist. The impact of the accidental and also an additional surgical trauma on the immune response has been clearly demonstrated. Therefore, the idea of a "damage control orthopedic surgery" (DCOS) is not only necessary to prevent further deterioration of the homeostasis of, e.g., the coagulating system, but is also desirable in terms of minimizing the burden on the immune system. In addition, also the timing of secondary surgical treatment in trauma patient care should include an evaluation of the immune response, although the most reliable markers still need to be identified. CONCLUSION: Immunomodulating therapies in trauma patients exist on an experimental level with inconsistent results. The general management of trauma patients includes strategies that have been developed also on the basis of immunological considerations.
BACKGROUND: [corrected] Severe injury leads to a severe deterioration of the patients' immune response. The changes of the immune response after severe injury include a broad range of immune functions and may result in a status of immunosuppression, which could favor infectious complications. Therefore, immunostimulating therapies have been introduced in the therapy for severely injured patients in clinical and experimental settings. OBJECTIVES: The article summarizes actual immunomodulating approaches in the treatment of traumapatients and therapeutic strategies avoiding additional immune deteriorations. RESULTS: Examples for an immunostimulating approach in traumapatients are interferon gamma and the granulocyte macrophage-colony-stimulating factor (GM-CSF), which are summarized in this review in detail. However, the effect of such an interference in the patients' immune response with all its different cellular targets is not yet clearly understood, and most studies focus on the reaction of circulating monocytes. In addition, further immunomodulating strategies, including nutritional support, are addressed. However, clinically established therapeutic immunomodulating strategies in trauma care so far do not exist. The impact of the accidental and also an additional surgical trauma on the immune response has been clearly demonstrated. Therefore, the idea of a "damage control orthopedic surgery" (DCOS) is not only necessary to prevent further deterioration of the homeostasis of, e.g., the coagulating system, but is also desirable in terms of minimizing the burden on the immune system. In addition, also the timing of secondary surgical treatment in traumapatient care should include an evaluation of the immune response, although the most reliable markers still need to be identified. CONCLUSION: Immunomodulating therapies in traumapatients exist on an experimental level with inconsistent results. The general management of traumapatients includes strategies that have been developed also on the basis of immunological considerations.
Authors: A K Mels; M G Statius Muller; P A van Leeuwen; B M von Blomberg; R J Scheper; M A Cuesta; R H Beelen; S Meijer Journal: Br J Surg Date: 2001-04 Impact factor: 6.939
Authors: Didier Keh; Thomas Boehnke; Steffen Weber-Cartens; Christina Schulz; Olaf Ahlers; Sven Bercker; Hans-Dieter Volk; Wolf-Dietrich Doecke; Konrad J Falke; Herwig Gerlach Journal: Am J Respir Crit Care Med Date: 2002-11-08 Impact factor: 21.405
Authors: S Flohé; J Börgermann; F E Domínguez; M Majetschak; L Lim; E Kreuzfelder; U Obertacke; D Nast-Kolb; F U Schade Journal: Shock Date: 1999-07 Impact factor: 3.454
Authors: D J Dries; G J Jurkovich; R V Maier; T P Clemmer; S N Struve; J A Weigelt; G G Stanford; D L Herr; H R Champion; F R Lewis Journal: Arch Surg Date: 1994-10
Authors: Albert Cheng; Casey E Vantucci; Laxminarayanan Krishnan; Marissa A Ruehle; Theresa Kotanchek; Levi B Wood; Krishnendu Roy; Robert E Guldberg Journal: Proc Natl Acad Sci U S A Date: 2021-02-23 Impact factor: 11.205
Authors: Sophie S Darwiche; Philipp Kobbe; Roman Pfeifer; Lauryn Kohut; Hans-Christoph Pape; Timothy Billiar Journal: J Vis Exp Date: 2011-04-18 Impact factor: 1.355